Title: SATO Liverurso (Liver Protection)

English Description:

SATO Liverurso is a highly effective liver support supplement featuring ursodeoxycholic acid (UDCA) and a liver hydrolysate. UDCA is a bile acid that reduces cholesterol levels in bile, primarily by dispersing cholesterol and forming a liquid-crystalline phase. It influences enterohepatic circulation of bile salts, reducing the reabsorption of more hydrophobic and potentially toxic endogenous compounds in the intestines. UDCA exerts a direct hepatoprotective effect and reduces the hepatotoxicity of hydrophobic bile salts. It lowers the lithogenic index of bile, increasing the bile acid content. When taken orally, it contributes to the partial or complete dissolution of cholesterol gallstones. It also possesses choleretic properties (stimulates bile production). The liver hydrolysate further enhances liver protection, stimulating cleansing and restoration of liver and stomach function. It also helps alleviate stress and fatigue associated with intense physical exertion.

Indications:

SATO Liverurso is indicated for a wide range of liver and biliary conditions, including:

• Gallstones: Uncomplicated gallstones, biliary sludge, dissolution of cholesterol gallstones (when surgical or endoscopic removal is impossible), and prevention of gallstone recurrence after cholecystectomy.
• Liver Diseases: Chronic active hepatitis, acute hepatitis, toxic liver damage (including drug-induced and alcohol-related), non-alcoholic steatohepatitis (NASH), primary biliary cirrhosis, primary sclerosing cholangitis, cystic fibrosis of the liver, biliary atresia (including congenital biliary atresia).
• Biliary Tract Disorders: Biliary dyskinesia, biliary reflux gastritis and esophagitis, biliary dyspeptic syndrome (in cholecystopathy and biliary dyskinesia).
• Preventive Measures: Prevention of liver damage associated with hormonal contraceptives and cytotoxic drugs.

Contraindications:

SATO Liverurso is contraindicated in patients with:

• Acute inflammatory diseases of the gallbladder and bile ducts
• Decompensated cirrhosis
• Severe kidney dysfunction
• Ulcerative colitis
• Crohn’s disease

SEO Keywords:

Ursodeoxycholic acid, UDCA, liver protection, liver support, hepatoprotective, gallstones, cholesterol gallstones, biliary sludge, chronic hepatitis, acute hepatitis, non-alcoholic steatohepatitis (NASH), primary biliary cirrhosis, primary sclerosing cholangitis, cystic fibrosis liver, biliary atresia, biliary dyskinesia, liver cleanse, liver health, SATO Liverurso, liver supplement, bile acid, choleretic, liver hydrolysate.